猪干扰素α、β和γ的融合表达及活性

doi:10.3864/j.issn.0578-1752.2012.09.020

摘要/Abstract

摘要： 【目的】研制高效的猪基因工程干扰素制剂用于猪病毒性和肿瘤性疾病的防治。【方法】采用重叠延伸PCR（splicing by overlap extension PCR，SOE-PCR）技术将PoIFN-α、PoIFN-β和PoIFN-γ成熟肽基因进行连接，形成3种融合基因PoIFN-α/β、PoIFN-α/γ和PoIFN-β/γ，并构建到原核表达载体pET30a进行融合表达，用细胞病变抑制试验和淋巴细胞转化试验测定融合蛋白rPoIFN-α/β、rPoIFN-α/γ和rPoIFN-β/γ的生物学活性，同时与非融合干扰素rPoIFN-α、rPoIFN-β和rPoIFN-γ进行比较分析。【结果】成功构建了3种融合基因，并在大肠杆菌中实现表达，经纯化、复性得到3种具有生物学活性的融合蛋白rPoIFN-α/β、rPoIFN-α/γ和rPoIFN-β/γ。细胞病变抑制试验结果表明，无论是在Marc-145还是在PK-15细胞上，3种融合蛋白均具有较强的抗病毒活性，其抗PRRSV或VSV活性明显高于非融合的rPoIFN-α、rPoIFN-β和rPoIFN-γ，体现出一定的叠加效应；MTT法检测淋巴细胞转化试验结果显示，rPoIFN-α/γ和rPoIFN-β/γ能有效刺激淋巴细胞转化，具有良好的免疫学活性；而rPoIFN-α/β效果不明显。说明Ⅰ型与Ⅱ型PoIFN之间能协同调节免疫，而Ⅰ型的不同亚型之间无明显协同作用。【结论】3种融合干扰素具有较强的抗病毒活性，可以用于猪病毒性和肿瘤性疾病的防治，其中rPoIFN-α/γ和rPoIFN-β/γ还具有较强的免疫增强作用，可被开发成新型的免疫增强剂。

关键词: 猪干扰素, 融合表达, 抗病毒活性, 细胞病变抑制, 猪淋巴细胞转化

Abstract: 【Objective】The research aimed to exploit high efficient porcine gene engineering antiviral agents to prevent and control the porcine viral diseases and tumor diseases.【Method】Three fusion genes of PoIFN-α/β, PoIFN-α/γ and PoIFN-β/γ were constructed by linking any two mature peptide genes of the PoIFN-α, PoIFN-β and PoIFN-γ by SOE-PCR method. Then, these fusion genes were subcloned into prokaryotic expression vector pET-30a for expression in E. coli BL21(DE3). Subsequently, the bioactivities of the fusion proteins rPoIFN-α/β, rPoIFN-α/γ and rPoIFN-β/γ were comparatively analyzed with non-fusion proteins rPoIFN-α, rPoIFN-β and rPoIFN-γ by the cytopathic effect (CPE) inhibition assay and the porcine lymphocyte transformation assay.【Result】The fusion genes of PoIFN-α/β, PoIFN-α/γ and PoIFN-β/γ were successfully constructed and expressed in E. coli. After purified and refolded from inclusion bodies, three fusion proteins of rPoIFN-α/β, rPoIFN-α/γ and rPoIFN-β/γ with well biological activity were obtained successfully. The results of the cytopathic effect (CPE) inhibition assay indicated that all these three kinds of fusion proteins, which demonstrated more significant antiviral activities for PRRSV or VSV than non-fusion proteins rPoIFN-α, rPoIFN-β and rPoIFN-γ not only on Marc-145 but also on PK-15, exhibited increased antiviral potencies. The effects of rPoIFN-α/β, rPoIFN-α/γ and rPoIFN-β/γ on the porcine lymphocyte transformation were detected by the MTT method. The results suggested that both rPoIFN-α/γ and rPoIFN-β/γ could effectively stimulate the transformation of porcine lymphocyte, had obvious immunoregulatory activities, but rPoIFN-α/β had no obvious effect. So, there are synergistic immunoregulatory effects between typeⅠand type Ⅱ PoIFNs, and none between PoIFNs of type Ⅰ.【Conclusion】 All these three fusion PoINFs in study, which exhibited the prominent abilities of antivirus, could be used to prevent and control the porcine viral diseases and tumor diseases. And the rPoIFN-α/γ and rPoIFN-β/γ also had stronger immune enhancement and could be expected to exploit into new-type immunopotentiators.

Key words: porcine interferon, fusion expression, antiviral activity, cytopathic effect inhibition, porcine lymphocyte transformation

郑鸣, 边传周, 王老七, 王永芬. 猪干扰素α、β和γ的融合表达及活性[J]. 中国农业科学, 2012, 45(9): 1840-1847.

ZHENG Ming, BIAN Chuan-Zhou, WANG Lao-Qi, WANG Yong-Fen. Study on the Fusion Expression and Bioactivity of Porcine Interferon α, β and γ[J]. Scientia Agricultura Sinica, 2012, 45(9): 1840-1847.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.chinaagrisci.com/CN/10.3864/j.issn.0578-1752.2012.09.020

https://www.chinaagrisci.com/CN/Y2012/V45/I9/1840

参考文献

[1]Esparza I, Gonzalez J C, Vinuela E. Effect of interferon-alpha, interferon-gamma and tumour necrosis factor on African swine fever virus replication in porcine monocytes and macrophages. Journal of General Virology, 1988, 69:2973-2980.

[2]Kalliolias G D, Ivashkiv L B. Overview of the biology of type I interferons. Arthritis Research & Therapy, 2010, 12(Suppl 1): 1-9.

[3]Sang Y M, Rowland R R R, Hesse R A, Blecha F. Differential expression and activity of the porcine type I interferon family. Physiological genomics, 2010, 42: 248-258.

[4]贺番, 孙元, 葛金英, 李淼, 常天明, 步志高, 仇华吉. 猪γ干扰素的表达及其抗病毒活性的安全检测. 生物工程学报, 2010, 26(4): 439-447.

He F, Sun Y, Ge J Y, Li M, Chang T M, Bu Z G, Qiu H J. Expression of porcine interferon-γ and its safe antiviral assay. Chinese Journal of Biotechnology, 2010, 26(4): 439-447. (in Chinese)

[5]Tang R S, Zhao J, Wang M L. Physicochemical characters of rPoIFN and its antiviral activity in vitro. Agricultural Science & Technology, 2010, 11(1): 65-68.

[6]Patel D, Nan Y C, Shen M Y, Ritthipichai K, Zhu X P, Zhang Y J. Porcine reproductive and respiratory syndrome virus inhibits type I Interferon signaling by blocking STAT1/STAT2 nuclear translocation. Journal of Virology, 2010, 21(84): 11045-11055.

[7]Overend C, Mitchell R, He D, Rompato G, Grubman M J, Garmendia A E. Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with porcine reproductive and respiratory syndrome virus. Journal of General Virology, 2007, 88: 925-931.

[8]Chinsangaram J, Moraes M P, Koster M, Grubman M J. Novel viral disease control strategy adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. Journal of Virology, 2003, 77(2): 1621-1625.

[9]June K, Chae C. Expression of Mx protein and interferon-α in pigs experimentally infected with swine influenza virus. Veterinary Pathology, 2006, 43:161-167.

[10]陈雪梅, 薛清华, 祝荣格, 付显华, 杨利敏, 孙蕾, 刘文军. 猪I 型与II 型干扰素的克隆、表达及抗病毒活性比较. 生物工程学报, 2009, 25(6): 806-812.

Chen X M, Xue Q H, Zhu R G, Fu X H, Yang L M, Sun L, Liu W J. Comparison of antiviral activities of porcine interferon type I and type II. Chinese Journal of Biotechnology, 2009, 25(6): 806-812. (in Chinese)

[11]Randall R E, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. Journal of General Virology, 2008, 89:1-47.

[12]Joshi S, Kaur S, Redig A J, Goldsborough K, David K, Ueda T, Watanabe-Fukunaga R, Baker D P, Fish E N, Fukunaga R, Platanias L C. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(29): 12097-12102.

[13]Kaur S, Sassano A, B Dolniak, Joshi S, Majchrzak-Kita B, Baker D P, Hay N, Fish E N, Platanias L C. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(12): 4808-4813.

[14]Der S D, Zhou A M, Williams B R G, Silverman R T H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95:15623-15628.

[15]Gilli F, Marnetto F, Caldano M, Sala A, Malucchi S, Capobianco M, Bertolotto A. Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. Multiple Sclerosis, 2006, 12: 47-57.

[16]Santos T de los, Botton S de A, Weiblen R, Grubman M J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. Journal of Virology, 2006, 80(4): 1906-1914.

[17]Goodbourn S, Didcock L, Randall R E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. Journal of General Virology, 2000, 81: 2341-2364.

[18]Hsiang T Y, Zhao C, Krug R M. Interferon-induced ISG15 conjugation inhibits influenza a virus gene expression and replication in human cells. Journal of Virology, 2009, 83(12): 5971-5977.

[19]Lipnik K, Naschberger E, Gonin-Laurent N, Kodajova P, Petznek H, Rungaldier S, Astigiano S, Ferrini S, Stürzl M, Hohenadl C. Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Molecular Medicine, 2010, 16(5-6): 177-187.

[20]张定勇, 孙蕾, 杨利敏, 刘文军. 猪β防御素2与猪γ干扰素在毕赤酵母中的融合表达及生物学活性比较. 生物工程学报, 2010, 26(12): 1652-1659.

Zhang D Y, Sun L, Yang L M, Liu W J. Fusion expression and bioactivity comparison of porcine β-defensin-2 and porcine interferon- gamma in Pichia pastoris. Chinese Journal of Biotechnology, 2010, 26(12): 1652-1659. (in Chinese)

[21]项黎丽, 闫若潜, 盛敏, 程增青. 犬α干扰素的克隆表达及纯化. 中国动物检疫, 2010, 27(1): 35-38.

Xiang L L, Yan R Q, Sheng M, Cheng Z Q. Cloning, expression and purification of canine interferon α (CaIFN-α). China Journal of Animal Quarantine, 2010, 27(1): 35-38. (in Chinese)

[22]闫若潜, 谢彩华, 吴志明, 张志凌, 刘光辉, 刘梅芬. 鸡α干扰素/白细胞介素2基因的融合表达及活性研究. 中国农业科学, 2010, 43(3): 594-604.

Yan R Q, Xie C H, Wu Z M, Zhang Z L, Liu G H, Liu M F. Study on the expression and bioactivity of chicken interferon α/chicken interleukin-2 fusion protein in vivo and in vitro. Scientia Agricultura Sinica, 2010, 43(3): 594-604. (in Chinese)

[23]Moraes M P, Santos T de los, Koster M, Turecek T, Wang H, Andreyev V G, Grubman M J. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. Journal of Virology, 2007, 81(13): 7124-7135.

[24]Pierce A T, DeSalvo J, Foster T P, Kosinski A, Weller S K, Halford W P. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. Journal of General Virology, 2005, 86: 2421-2432.

[25]Yao Q X, Qian P, Cao Y, He Y N, Si Y H, Xu Z F, Chen H C. Synergistic inhibition of pseudorabies virus replication by porcine alphabeta interferon and gamma interferon in vitro. European Cytokine Network, 2007, 18(2): 71-77.

[26]Desloges N, Rahaus M, Wolff M H. Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. Journal of General Virology, 2005, 86: 1-6.

[27]王彦彬, 卢中华, 康相涛, 宋素芳, 孙桂荣, 韩瑞丽, 李国喜, 李守义. 固始鸡白细胞介素2基因的克隆、表达及其表达蛋白活性的检测. 西北农林科技大学学报: 自然科学版, 2006, 5(34): 66-71.

Wang Y B, Lu Z H, Kang X T, Song S F, Sun G R, Han D L, Li G X, Li S Y. Cloning and expression of gushi-chicken interleukin 2 gene and detection of its biological activity. Journal of Northwest Sci-Tech University of Agriculture and Forestry: Natural Science Edition, 2006, 5(34) : 66-71. (in Chinese)